Ionis Pharmaceuticals Inc... (IONS)
NASDAQ: IONS
· Real-Time Price · USD
72.39
1.02 (1.43%)
At close: Oct 15, 2025, 3:59 PM
72.31
-0.11%
After-hours: Oct 15, 2025, 07:07 PM EDT
Ionis Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 705.14M | 787.65M | 587M | 810M |
Cost of Revenue | 11.21M | 9.13M | 14M | 11M |
Gross Profit | 693.92M | 778.51M | 573M | 799M |
Operating Income | -475.08M | -353.73M | -411M | -30.19M |
Interest Income | -6K | 89.04M | 25.33M | 10.04M |
Pretax Income | -460.07M | -333.96M | -258M | -29.15M |
Net Income | -453.9M | -366.29M | -270M | -28.6M |
Selling & General & Admin | 267.5M | 232.6M | 151M | 186M |
Research & Development | 901.53M | 899.63M | 833M | 643M |
Other Expenses | -26K | 19K | n/a | n/a |
Operating Expenses | 1.17B | 1.13B | 984M | 829M |
Interest Expense | 90.45M | 81.46M | 8.12M | 9.35M |
Selling & Marketing Expenses | n/a | n/a | 700K | 15.1M |
Cost & Expenses | 1.18B | 1.14B | 998M | 840M |
Income Tax Expense | -6.17M | 32.32M | 11.74M | -551K |
Shares Outstanding (Basic) | 149.51M | 143M | 141.85M | 141.02M |
Shares Outstanding (Diluted) | 149.51M | 143.19M | 141.85M | 141.02M |
EPS (Basic) | -3.04 | -2.56 | -1.9 | -0.2 |
EPS (Diluted) | -3.04 | -2.56 | -1.9 | -0.2 |
EBITDA | -475.08M | -230.01M | -227.76M | -239K |
EBIT | -477.06M | -252.51M | -249.86M | -19.8M |
Depreciation & Amortization | 1.98M | 22.5M | 22.11M | 19.56M |
Source: Financial Modeling Prep. Financial Sources.